Literature DB >> 30484123

CylA is a sequence-specific protease involved in toxin biosynthesis.

Weixin Tang1, Silvia C Bobeica1, Li Wang2, Wilfred A van der Donk3.   

Abstract

CylA is a subtilisin-like protein belonging to a recently expanded serine protease family related to class II lanthipeptide biosynthesis. As a leader peptidase, CylA is responsible for maturation of the enterococcal cytolysin, a lantibiotic important for Enterococcus faecalis virulence. In vitro reconstitution of CylA reveals that it accepts both linear and modified cytolysin peptides with a preference for cyclized peptides. Further characterization indicates that CylA activates itself by removing its N-terminal 95 amino acids. CylA achieves sequence-specific traceless cleavage of non-cognate peptides even if they are post-translationally modified, which makes the peptidase a powerful tool for mining novel lanthipeptides by providing a general strategy for leader peptide removal. Knowledge about the substrate specificity of CylA may also facilitate the development of protease inhibitors targeting cytolysin biosynthesis as a potential therapeutic approach for enterococcal infections.

Entities:  

Keywords:  Lanthipeptides; Lantibiotics; Leader peptide; Natural products; Peptidase; RiPPs

Mesh:

Substances:

Year:  2018        PMID: 30484123      PMCID: PMC6450559          DOI: 10.1007/s10295-018-2110-9

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  49 in total

Review 1.  Synthesis of native proteins by chemical ligation.

Authors:  P E Dawson; S B Kent
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 2.  Semisynthesis of proteins by expressed protein ligation.

Authors:  Tom W Muir
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

Review 3.  Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells.

Authors:  Christopher R Cox; Phillip S Coburn; Michael S Gilmore
Journal:  Curr Protein Pept Sci       Date:  2005-02       Impact factor: 3.272

Review 4.  Bacterial lantibiotics: strategies to improve therapeutic potential.

Authors:  Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Curr Protein Pept Sci       Date:  2005-02       Impact factor: 3.272

5.  Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.

Authors:  Amanda L McClerren; Lisa E Cooper; Chao Quan; Paul M Thomas; Neil L Kelleher; Wilfred A van der Donk
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

6.  Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.

Authors:  Elaine M Lawton; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  FEMS Microbiol Lett       Date:  2007-02       Impact factor: 2.742

Review 7.  Lantibiotics: mode of action, biosynthesis and bioengineering.

Authors:  G Bierbaum; H-G Sahl
Journal:  Curr Pharm Biotechnol       Date:  2009-01       Impact factor: 2.837

8.  In vitro reconstitution and substrate specificity of a lantibiotic protease.

Authors:  L A Furgerson Ihnken; Champak Chatterjee; Wilfred A van der Donk
Journal:  Biochemistry       Date:  2008-06-21       Impact factor: 3.162

9.  Chapter 21. In vitro studies of lantibiotic biosynthesis.

Authors:  Bo Li; Lisa E Cooper; Wilfred A van der Donk
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

10.  Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis.

Authors:  Bo Li; John Paul J Yu; Joseph S Brunzelle; Gert N Moll; Wilfred A van der Donk; Satish K Nair
Journal:  Science       Date:  2006-03-10       Impact factor: 47.728

View more
  5 in total

1.  LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome.

Authors:  Kuan-Yu Lai; Sébastien R G Galan; Yibo Zeng; Tianhui Hina Zhou; Chang He; Ritu Raj; Jitka Riedl; Shi Liu; K Phin Chooi; Neha Garg; Min Zeng; Lyn H Jones; Graham J Hutchings; Shabaz Mohammed; Satish K Nair; Jie Chen; Benjamin G Davis; Wilfred A van der Donk
Journal:  Cell       Date:  2021-04-30       Impact factor: 41.582

Review 2.  New developments in RiPP discovery, enzymology and engineering.

Authors:  Manuel Montalbán-López; Thomas A Scott; Sangeetha Ramesh; Imran R Rahman; Auke J van Heel; Jakob H Viel; Vahe Bandarian; Elke Dittmann; Olga Genilloud; Yuki Goto; María José Grande Burgos; Colin Hill; Seokhee Kim; Jesko Koehnke; John A Latham; A James Link; Beatriz Martínez; Satish K Nair; Yvain Nicolet; Sylvie Rebuffat; Hans-Georg Sahl; Dipti Sareen; Eric W Schmidt; Lutz Schmitt; Konstantin Severinov; Roderich D Süssmuth; Andrew W Truman; Huan Wang; Jing-Ke Weng; Gilles P van Wezel; Qi Zhang; Jin Zhong; Jörn Piel; Douglas A Mitchell; Oscar P Kuipers; Wilfred A van der Donk
Journal:  Nat Prod Rep       Date:  2020-09-16       Impact factor: 15.111

3.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.

Authors:  Yi Duan; Cristina Llorente; Sonja Lang; Katharina Brandl; Huikuan Chu; Lu Jiang; Richard C White; Thomas H Clarke; Kevin Nguyen; Manolito Torralba; Yan Shao; Jinyuan Liu; Adriana Hernandez-Morales; Lauren Lessor; Imran R Rahman; Yukiko Miyamoto; Melissa Ly; Bei Gao; Weizhong Sun; Roman Kiesel; Felix Hutmacher; Suhan Lee; Meritxell Ventura-Cots; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Samuel B Ho; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Xin M Tu; Lars Eckmann; Wilfred A van der Donk; Ry Young; Trevor D Lawley; Peter Stärkel; David Pride; Derrick E Fouts; Bernd Schnabl
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

4.  Maturation of subtilisin-like protease NbSLP1 from microsporidia Nosema bombycis.

Authors:  Rong Wang; Qingyan Li; Fangyan Liu; Xiaoqun Dang; Quan Sun; Xiaotian Sheng; Mingyu Hu; Jialing Bao; Jie Chen; Guoqing Pan; Zeyang Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

5.  Structure-Activity Relationships of the Enterococcal Cytolysin.

Authors:  Imran R Rahman; Alondra Sanchez; Weixin Tang; Wilfred A van der Donk
Journal:  ACS Infect Dis       Date:  2021-07-15       Impact factor: 5.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.